INTRODUCTION {#sec1}
============

The fluoroquinolone class of antibiotics is currently used as standard empirical therapy in health care-associated infections and community-acquired infections; specifically, antibiotics of this class are indicated for the treatment of urinary tract infections (UTI), respiratory tract infections (RTI), acute bacterial skin and skin structure infections (ABSSSI), and intra-abdominal infections ([@B1][@B2][@B6]). A recent point-prevalence study of antimicrobial use in U.S. acute care hospitals found levofloxacin to be the third most common antimicrobial agent prescribed to treat both community-acquired infections and health care-acquired infections ([@B7]). In the face of such broad utilization, the emergence of fluoroquinolone resistance has been observed in both Gram-positive cocci (GPC) and Gram-negative bacilli (GNB) ([@B1], [@B6], [@B8]).

Fluoroquinolones are the only class of antibiotics in clinical use that directly target two essential bacterial enzymes in DNA replication: DNA gyrase and topoisomerase IV ([@B1], [@B9]). Resistance to fluoroquinolones is primarily caused by target mutations (e.g., mutations in chromosomal genes that encode the subunits of DNA gyrase and topoisomerase IV), efflux pumps, and reduced target expression ([@B9]). These mechanisms may occur in various combinations in resistant strains of staphylococci, Pseudomonas aeruginosa, and Enterobacteriaceae ([@B1], [@B6]). Efforts to combat this resistance to the fluoroquinolone class have focused on improving activity against multidrug-resistant bacteria and providing a lower potential for the development of bacterial resistance ([@B1], [@B4], [@B5], [@B8]).

Delafloxacin is an anionic investigational fluoroquinolone with documented efficacy in phase 2 trials for the treatment of RTI and ABSSSI and has recently completed phase 3 trials for the treatment of ABSSSI ([@B1], [@B10]). Unlike other quinolones, which usually have a binding affinity for either DNA gyrase or topoisomerase IV, delafloxacin is equally potent against both enzymes ([@B1], [@B11][@B12][@B13]). This dual targeting is believed to help reduce the selection of resistant mutants *in vitro* and *in vivo* ([@B11], [@B12], [@B14]). Unlike other fluoroquinolones, the mutant prevention concentration for delafloxacin is within 1- to −2-log~2~ dilutions of the MIC value ([@B13]). Additionally, the anionic structure of delafloxacin may enhance its potency in acidic environments, characteristic of the milieu at an infection site ([@B1], [@B13], [@B15]).

Delafloxacin is active *in vitro* against a broad range of Gram-positive and Gram-negative bacteria, including anaerobes and atypical respiratory tract pathogens (e.g., Legionella, Chlamydia, and Mycoplasma) ([@B1], [@B13], [@B16][@B17][@B18]). Delafloxacin exhibits very low MIC values against Gram-positive pathogens, including fluoroquinolone-resistant strains of Staphylococcus aureus, coagulase-negative staphylococci (CoNS), and Streptococcus pneumoniae ([@B1], [@B12], [@B13], [@B19]). It has been shown to be highly active *in vitro* against pathogens that are found in ABSSSI, including methicillin-resistant S. aureus (MRSA), methicillin-resistant coagulase-negative staphylococci (MR-CoNS), beta-hemolytic streptococci, Enterobacteriaceae, P. aeruginosa, and anaerobes ([@B10], [@B11], [@B13], [@B16], [@B20]). Delafloxacin is also active against bacteria associated with RTIs, including S. pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis ([@B19]).

The aim of the present study was to examine the susceptibility profiles of delafloxacin and comparator agents when tested against contemporary clinical isolates collected from European and U.S. medical centers during surveillance year 2014.

RESULTS AND DISCUSSION {#sec2}
======================

Overall activity of delafloxacin. {#sec2-1}
---------------------------------

The MIC distributions for select organisms or organism groups from U.S. and European medical centers are shown in [Table 1](#T1){ref-type="table"}. The MIC~90~ values for U.S. and European isolates of GPC were within ±1 log~2~ dilution step for each organism group except methicillin-susceptible S. aureus (MSSA) (MIC~90~s, 0.03 and ≤0.004 μg/ml for U.S. and European isolates, respectively) and methicillin-susceptible coagulase-negative staphylococci (MS-CoNS; MIC~90~s, 0.12 and 0.008 μg/ml for U.S. and European isolates, respectively) (data not shown).

###### 

Cumulative frequency distribution of delafloxacin in MIC results for Europe and the United States[^*a*^](#T1F1){ref-type="table-fn"}

  Organism or organism group                     No. (%) of isolates for which MIC (μg/ml) was:   MIC~50~ (μg/ml)   MIC~90~ (μg/ml)                                                                                                                                             
  ---------------------------------------------- ------------------------------------------------ ----------------- ----------------- ------------ ------------ ------------ ------------ ----------- ----------- ------------ ------------ ------------ ------------- -------- --------
  Staphylococcus aureus                                                                                                                                                                                                                                                         
      US                                         1,100                                            666 (60.5)        8 (61.3)          8 (62.0)     38 (65.5)    183 (82.1)   62 (87.7)    63 (93.5)   24 (95.6)   34 (98.7)    0 (98.7)     14 (100.0)   0 (100.0)     ≤0.004   0.25
      EU                                         250                                              193 (77.2)        2 (78.0)          1 (78.4)     4 (80.0)     12 (84.8)    13 (90.0)    18 (97.2)   3 (98.4)    3 (99.6)     0 (99.6)     1 (100.0)    0 (100.0)     ≤0.004   0.12
  MSSA                                                                                                                                                                                                                                                                          
      US                                         591                                              515 (87.1)        7 (88.3)          4 (89.0)     10 (90.7)    27 (95.3)    11 (97.1)    8 (98.5)    6 (99.5)    2 (99.8)     0 (99.8)     1 (100.0)    0 (100.0)     ≤0.004   0.03
      EU                                         186                                              176 (94.6)        2 (95.7)          1 (96.2)     2 (97.3)     1 (97.8)     2 (98.9)     1 (99.5)    0 (99.5)    1 (100.0)                              0 (100.0)     ≤0.004   ≤0.004
  MRSA                                                                                                                                                                                                                                                                          
      US                                         509                                              151 (29.7)        1 (29.9)          4 (30.6)     28 (36.1)    156 (66.8)   51 (76.8)    55 (87.6)   18 (91.2)   32 (97.4)    0 (97.4)     13 (100.0)   0 (100.0)     0.06     0.5
      EU                                         64                                               17 (26.6)         0 (26.6)          0 (26.6)     2 (29.7)     11 (46.9)    11 (64.1)    17 (90.6)   3 (95.3)    2 (98.4)     0 (98.4)     1 (100.0)    0 (100.0)     0.12     0.25
  Coagulase-negative staphylococci                                                                                                                                                                                                                                              
      US                                         100                                              51 (51.0)         7 (58.0)          3 (61.0)     1 (62.0)     6 (68.0)     14 (82.0)    4 (86.0)    4 (90.0)    9 (99.0)     1 (100.0)                 0 (100.0)     ≤0.004   0.5
      EU                                         100                                              43 (43.0)         8 (51.0)          1 (52.0)     6 (58.0)     10 (68.0)    10 (78.0)    14 (92.0)   5 (97.0)    3 (100.0)                              0 (100.0)     0.008    0.25
  Enterococcus faecalis                                                                                                                                                                                                                                                         
      US                                         300                                              0 (0.0)           2 (0.7)           0 (0.7)      28 (10.0)    150 (60.0)   39 (73.0)    9 (76.0)    27 (85.0)   37 (97.3)    8 (100.0)                 0 (100.0)     0.06     1
      EU                                         150                                              2 (1.3)           2 (2.7)           0 (2.7)      16 (13.3)    57 (51.3)    31 (72.0)    3 (74.0)    17 (85.3)   22 (100.0)                             0 (100.0)     0.06     1
  Enterococcus faecium                                                                                                                                                                                                                                                          
      US                                         195                                                                0 (0.0)           1 (0.5)      0 (0.5)      8 (4.6)      0 (4.6)      1 (5.1)     6 (8.2)     8 (12.3)     3 (13.8)     16 (22.1)    152 (100.0)   \>4      \>4
      EU                                         100                                              0 (0.0)           1 (1.0)           1 (2.0)      0 (2.0)      0 (2.0)      0 (2.0)      2 (4.0)     1 (5.0)     2 (7.0)      1 (8.0)      7 (15.0)     85 (100.0)    \>4      \>4
  Streptococcus pneumoniae                                                                                                                                                                                                                                                      
      US                                         300                                              34 (11.3)         169 (67.7)        84 (95.7)    7 (98.0)     3 (99.0)     2 (99.7)     1 (100.0)                                                      0 (100.0)     0.008    0.015
      EU                                         150                                              16 (10.7)         90 (70.7)         40 (97.3)    4 (100.0)                                                                                             0 (100.0)     0.008    0.015
  Viridans group streptococci                                                                                                                                                                                                                                                   
      US                                         196                                              34 (17.3)         41 (38.3)         71 (74.5)    34 (91.8)    7 (95.4)     4 (97.4)     2 (98.5)    1 (99.0)    1 (99.5)     1 (100.0)                 0 (100.0)     0.015    0.03
      EU                                         98                                               19 (19.4)         19 (38.8)         30 (69.4)    18 (87.8)    8 (95.9)     0 (95.9)     3 (99.0)    1 (100.0)                                          0 (100.0)     0.015    0.06
  Streptococcus pyogenes                                                                                                                                                                                                                                                        
      US                                         283                                              67 (23.7)         170 (83.7)        46 (100.0)                                                                                                         0 (100.0)     0.008    0.015
      EU                                         150                                              33 (22.0)         94 (84.7)         20 (98.0)    3 (100.0)                                                                                             0 (100.0)     0.008    0.015
  Streptococcus agalactiae                                                                                                                                                                                                                                                      
      US                                         150                                              18 (12.0)         70 (58.7)         56 (96.0)    3 (98.0)     0 (98.0)     1 (98.7)     1 (99.3)    1 (100.0)                                          0 (100.0)     0.008    0.015
      EU                                         75                                               5 (6.7)           38 (57.3)         28 (94.7)    1 (96.0)     1 (97.3)     1 (98.7)     1 (100.0)                                                      0 (100.0)     0.008    0.015
  Streptococcus dysgalactiae                                                                                                                                                                                                                                                    
      US                                         82                                               19 (23.2)         51 (85.4)         11 (98.8)    1 (100.0)                                                                                             0 (100.0)     0.008    0.015
      EU                                         50                                               18 (36.0)         30 (96.0)         1 (98.0)     1 (100.0)                                                                                             0 (100.0)     0.008    0.008
  Enterobacteriaceae                                                                                                                                                                                                                                                            
      US                                         1,500                                            3 (0.2)           16 (1.3)          132 (10.1)   261 (27.5)   389 (53.4)   163 (64.3)   74 (69.2)   94 (75.5)   102 (82.3)   116 (90.0)   70 (94.7)    80 (100.0)    0.06     2
      EU                                         750                                              1 (0.1)           11 (1.6)          81 (12.4)    118 (28.1)   196 (54.3)   76 (64.4)    25 (67.7)   30 (71.7)   49 (78.3)    64 (86.8)    44 (92.7)    55 (100.0)    0.06     4
  Escherichia coli                                                                                                                                                                                                                                                              
      US                                         300                                              2 (0.7)           11 (4.3)          77 (30.0)    71 (53.7)    14 (58.3)    13 (62.7)    7 (65.0)    3 (66.0)    11 (69.7)    34 (81.0)    34 (92.3)    23 (100.0)    0.03     4
      EU                                         200                                              1 (0.5)           9 (5.0)           61 (35.5)    43 (57.0)    14 (64.0)    8 (68.0)     9 (72.5)    2 (73.5)    6 (76.5)     24 (88.5)    16 (96.5)    7 (100.0)     0.03     4
  E. coli isolates of the ESBL phenotype                                                                                                                                                                                                                                        
      US                                         52                                               0 (0.0)           1 (1.9)           2 (5.8)      2 (9.6)      2 (13.5)     1 (15.4)     1 (17.3)    1 (19.2)    4 (26.9)     17 (59.6)    14 (86.5)    7 (100.0)     2        \>4
      EU                                         40                                                                 0 (0.0)           3 (7.5)      4 (17.5)     0 (17.5)     1 (20.0)     2 (25.0)    0 (25.0)    2 (30.0)     11 (57.5)    11 (85.0)    6 (100.0)     2        \>4
  Klebsiella pneumoniae                                                                                                                                                                                                                                                         
      US                                         225                                                                0 (0.0)           2 (0.9)      30 (14.2)    108 (62.2)   25 (73.3)    11 (78.2)   11 (83.1)   6 (85.8)     4 (87.6)     11 (92.4)    17 (100.0)    0.06     4
      EU                                         164                                                                0 (0.0)           1 (0.6)      12 (7.9)     64 (47.0)    14 (55.5)    2 (56.7)    5 (59.8)    7 (64.0)     10 (70.1)    17 (80.5)    32 (100.0)    0.12     \>4
  K. pneumoniae isolates of the ESBL phenotype                                                                                                                                                                                                                                  
      US                                         35                                                                                                0 (0.0)      1 (2.9)      1 (5.7)      0 (5.7)     2 (11.4)    4 (22.9)     2 (28.6)     9 (54.3)     16 (100.0)    4        \>4
      EU                                         67                                                                                                0 (0.0)      4 (6.0)      2 (9.0)      0 (9.0)     1 (10.4)    4 (16.4)     8 (28.4)     17 (53.7)    31 (100.0)    4        \>4
  Klebsiella oxytoca                                                                                                                                                                                                                                                            
      US                                         75                                                                                   0 (0.0)      3 (4.0)      44 (62.7)    23 (93.3)    3 (97.3)    2 (100.0)                                          0 (100.0)     0.06     0.12
      EU                                         36                                                                                   0 (0.0)      4 (11.1)     18 (61.1)    11 (91.7)    1 (94.4)    1 (97.2)    1 (100.0)                              0 (100.0)     0.06     0.12
  Pseudomonas aeruginosa                                                                                                                                                                                                                                                        
      US                                         100                                                                0 (0.0)           1 (1.0)      1 (2.0)      7 (9.0)      26 (35.0)    22 (57.0)   8 (65.0)    10 (75.0)    7 (82.0)     6 (88.0)     12 (100.0)    0.25     \>4
      EU                                         100                                                                                  0 (0.0)      1 (1.0)      3 (4.0)      22 (26.0)    28 (54.0)   11 (65.0)   8 (73.0)     1 (74.0)     7 (81.0)     19 (100.0)    0.25     \>4
  Acinetobacter baumannii-A. calcoaceticus                                                                                                                                                                                                                                      
      US                                         100                                                                0 (0.0)           1 (1.0)      10 (11.0)    21 (32.0)    11 (43.0)    4 (47.0)    7 (54.0)    5 (59.0)     8 (67.0)     8 (75.0)     25 (100.0)    0.5      \>4
      EU                                         100                                                                                  0 (0.0)      3 (3.0)      8 (11.0)     5 (16.0)     1 (17.0)    5 (22.0)    7 (29.0)     18 (47.0)    27 (74.0)    26 (100.0)    4        \>4

Abbreviations: EU, Europe; US, United States; MSSA, methicillin-susceptible S. aureus; MRSA, methicillin-resistant S. aureus; ESBL, extended-spectrum β-lactamase.

Delafloxacin showed very low MICs against Gram-positive pathogens ([Table 1](#T1){ref-type="table"}). Among the S. aureus isolates, 99.5% of MSSA isolates from both U.S. and European study sites were inhibited at the pharmacodynamic breakpoint of ≤0.5 μg/ml ([@B1], [@B13], [@B21]). European isolates of MRSA, MS-CoNS, and MR-CoNS were slightly more susceptible to delafloxacin than U.S. isolates at an MIC of ≤0.5 μg/ml (for MRSA isolates, 95.3 and 91.2% isolates from Europe and the United States, respectively; for MS-CoNS isolates, 100.0 and 97.6% isolates from Europe and the United States, respectively; and for MR-CoNS isolates, 95.5 and 84.5% isolates from Europe and the United States, respectively) (data not shown). Notably, among fluoroquinolone-resistant (FQ^r^) strains of S. aureus and CoNS, 88.3% (484/548) were inhibited by ≤0.5 μg/ml of delafloxacin (data not shown).

The potency of delafloxacin against U.S. and European isolates of enterococci and streptococci was similar ([Table 1](#T1){ref-type="table"}). Delafloxacin was most active against isolates of S. pneumoniae and beta-hemolytic streptococci (MIC~50~ and MIC~90~, 0.008 and 0.015 μg/ml, respectively, for each group of organisms) and viridans group streptococci (MIC~50~ and MIC~90~, 0.015 and 0.03 μg/ml, respectively). All FQ^r^ strains of S. pneumoniae (5/5) were inhibited by ≤0.25 μg/ml of delafloxacin. The MIC~50~ and MIC~90~ against U.S. and European isolates of E. faecalis were 0.06 and 1 μg/ml, respectively, whereas isolates of Enterococcus faecium were not susceptible to delafloxacin ([Table 1](#T1){ref-type="table"}).

Similar to the activity of delafloxacin against GPC, the activity of delafloxacin was comparable against isolates of GNB from the United States and Europe, with the exception of Enterobacter spp. (MIC~90~s, 0.5 μg/ml for U.S. isolates and 2 μg/ml for European isolates), Providencia spp. (MIC~90~s, \>4 μg/ml for U.S. isolates and 1 μg/ml for European isolates), other Enterobacteriaceae (MIC~90~s, 0.5 μg/ml for U.S. isolates and 0.12 μg/ml for European isolates), and Acinetobacter baumannii-A. calcoaceticus (MIC~50~, 0.5 μg/ml for U.S. isolates and 4 μg/ml for European isolates). Delafloxacin was most active against Klebsiella oxytoca (MIC~50~ and MIC~90~, 0.06 and 0.12 μg/ml, respectively), Enterobacter aerogenes (MIC~50~ and MIC~90~, 0.12 and 0.25 μg/ml, respectively), Citrobacter koseri (MIC~50~ and MIC~90~, 0.015 and 0.06 μg/ml, respectively), and other Enterobacteriaceae (MIC~50~ and MIC~90~, 0.06 and 0.25 μg/ml, respectively) and was the least active against Klebsiella pneumoniae, Providencia spp., P. aeruginosa, and Acinetobacter baumannii-A. calcoaceticus (MIC~90~s, \>4 μg/ml for all isolates) ([Table 1](#T1){ref-type="table"}). The activity of delafloxacin was considerably greater against strains of E. coli of the non-extended-spectrum β-lactamase \[ESBL\]-producing phenotype (non-ESBL phenotype) than strains of E. coli of the ESBL-producing phenotype (ESBL phenotype) (MIC~50~, 0.03 μg/ml versus 2 μg/ml, respectively), non-ESBL-phenotype and ESBL-phenotype strains of K. pneumoniae (MIC~50~, 0.06 μg/ml versus 4 μg/ml, respectively), and non-ESBL-phenotype and ESBL-phenotype strains of P. mirabilis (MIC~50~, 0.06 μg/ml versus 2 μg/ml, respectively). Delafloxacin retained potent activity against ESBL-phenotype strains of K. oxytoca (MIC~50~ and MIC~90~, 0.06 and 0.12 μg/ml, respectively) and was more active against ceftazidime-susceptible than ceftazidime-nonsusceptible strains of P. aeruginosa (MIC~50~, 0.25 μg/ml versus 4 μg/ml, respectively). More than 90% of FQ^r^ GNB showed decreased susceptibility (MIC, ≥2 μg/ml) to delafloxacin.

Susceptibilities of European and U.S. Gram-positive isolates to delafloxacin and comparator agents. {#sec2-2}
---------------------------------------------------------------------------------------------------

The activities of delafloxacin and comparator agents tested against European (250 isolates) and U.S. (1,100 isolates) isolates of S. aureus are shown in [Table 2](#T2){ref-type="table"}. Delafloxacin was the most potent antimicrobial agent tested against isolates of MSSA (MIC~50~ and MIC~90~, ≤0.004 and 0.008 μg/ml, respectively) and on the basis of the MIC~90~s was 8- to at least 64-fold more potent than ceftaroline and at least 64-fold more potent than levofloxacin ([Table 2](#T2){ref-type="table"}). Tigecycline (MIC~50~ and MIC~90~, 0.06 and 0.06 μg/ml, respectively), delafloxacin (MIC~50~ and MIC~90~, 0.06 and 0.5 μg/ml, respectively), and daptomycin (MIC~50~ and MIC~90~, 0.25 and 0.5 μg/ml, respectively) were the most potent agents tested against MRSA ([Table 2](#T2){ref-type="table"}). Delafloxacin was at least 64-fold more potent than levofloxacin (according to the MIC~50~s) and at least 8-fold more potent than ceftaroline against MRSA. MRSA strains exhibited high levels of resistance against levofloxacin (68.9 and 68.9% according to Clinical and Laboratory Standards Institute \[CLSI\] and European Committee on Antimicrobial Susceptibility Testing \[EUCAST\] criteria, respectively) and erythromycin (79.9 and 83.8% according to CLSI and EUCAST criteria, respectively) ([Table 2](#T2){ref-type="table"}). The greatest coverage of all S. aureus isolates (MSSA and MRSA isolates from both Europe and the United States) was provided by linezolid, tigecycline, and vancomycin (to which 100.0% of isolates were susceptible). Isolates from both Europe and United States also exhibited high levels of susceptibility to daptomycin (99.8% of isolates were susceptible), ceftaroline (98.0%), and trimethoprim-sulfamethoxazole (98.5%) ([Table 2](#T2){ref-type="table"}).

###### 

Activities of delafloxacin and comparator antimicrobial agents when tested against U.S. and European Gram-positive isolates

  Organism group (no. of isolates tested)/antimicrobial agent   \% of isolates susceptible by the following criteria:                                                                       MIC (μg/ml)                                                                                           
  ------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------- -------- -------- ------------------
  Staphylococcus aureus (1,350)                                                                                                                                                                                                                                                                   
      Delafloxacin                                                                                                                                                                                                                                                              ≤0.004   0.25     ≤0.004 to 4
      Levofloxacin                                              64.4                                                                                                                        64.4                                                                                0.25     \>4      ≤0.12 to \>4
      Ceftaroline                                               98.0                                                                                                                        98.0                                                                                0.25     1        0.03 to 2
      Ciprofloxacin                                             0.0                                                                                                                         0.0                                                                                 64       \>128    64 to \>128
      Clindamycin                                               87.0                                                                                                                        86.8                                                                                ≤0.25    \>2      ≤0.25 to \>2
      Daptomycin                                                99.8                                                                                                                        99.8                                                                                0.25     0.5      ≤0.06 to 2
      Erythromycin                                              45.9                                                                                                                        46.3                                                                                4        \>16     ≤0.12 to \>16
      Linezolid                                                 100.0                                                                                                                       100.0                                                                               1        1        0.25 to 2
      Oxacillin                                                 57.6                                                                                                                        57.6                                                                                0.5      \>2      ≤0.25 to \>2
      Tetracycline                                              94.3                                                                                                                        92.5                                                                                ≤0.5     ≤0.5     ≤0.5 to \>8
      Tigecycline                                               100.0[^*a*^](#T2F1){ref-type="table-fn"}                                                                                    100.0                                                                               0.06     0.06     ≤0.015 to 0.5
      Trimethoprim-sulfamethoxazole                             98.5                                                                                                                        98.5                                                                                ≤0.5     ≤0.5     ≤0.5 to \>4
      Vancomycin                                                100.0                                                                                                                       100.0                                                                               1        1        0.25 to 2
  MSSA (777)                                                                                                                                                                                                                                                                                      
      Delafloxacin                                                                                                                                                                                                                                                              ≤0.004   0.008    ≤0.004 to 4
      Levofloxacin                                              89.8                                                                                                                        89.8                                                                                0.25     2        ≤0.12 to \>4
      Ceftaroline                                               100.0                                                                                                                       100.0                                                                               0.25     0.25     0.03 to 1
      Ciprofloxacin                                             0.0                                                                                                                         0.0                                                                                 \>128    \>128    \>128 to \>128
      Clindamycin                                               94.0                                                                                                                        93.7                                                                                ≤0.25    ≤0.25    ≤0.25 to \>2
      Daptomycin                                                100.0                                                                                                                       100.0                                                                               0.25     0.5      ≤0.06 to 1
      Erythromycin                                              69.6                                                                                                                        69.8                                                                                0.25     \>16     ≤0.12 to \>16
      Linezolid                                                 100.0                                                                                                                       100.0                                                                               1        1        0.25 to 2
      Oxacillin                                                 100.0                                                                                                                       100.0                                                                               0.5      0.5      ≤0.25 to 2
      Tetracycline                                              95.9                                                                                                                        94.2                                                                                ≤0.5     ≤0.5     ≤0.5 to \>8
      Tigecycline                                               100.0[^*a*^](#T2F1){ref-type="table-fn"}                                                                                    100.0                                                                               0.06     0.06     ≤0.015 to 0.5
      Trimethoprim-sulfamethoxazole                             99.0                                                                                                                        99.0                                                                                ≤0.5     ≤0.5     ≤0.5 to \>4
      Vancomycin                                                100.0                                                                                                                       100.0                                                                               1        1        0.25 to 2
  MRSA (573)                                                                                                                                                                                                                                                                                      
      Delafloxacin                                                                                                                                                                                                                                                              0.06     0.5      ≤0.004 to 4
      Levofloxacin                                              30.0                                                                                                                        30.0                                                                                4        \>4      ≤0.12 to \>4
      Ceftaroline                                               95.3                                                                                                                        95.3                                                                                1        1        0.25 to 2
      Ciprofloxacin                                             0.0                                                                                                                         0.0                                                                                 \>128    \>128    64 to \>128
      Clindamycin                                               77.5                                                                                                                        77.5                                                                                ≤0.25    \>2      ≤0.25 to \>2
      Daptomycin                                                99.5                                                                                                                        99.5                                                                                0.25     0.5      0.12 to 2
      Erythromycin                                              13.8                                                                                                                        14.3                                                                                \>16     \>16     ≤0.12 to \>16
      Linezolid                                                 100.0                                                                                                                       100.0                                                                               1        1        0.25 to 2
      Oxacillin                                                 0.0                                                                                                                         0.0                                                                                 \>2      \>2      \>2 to \>2
      Tetracycline                                              92.1                                                                                                                        90.2                                                                                ≤0.5     1        ≤0.5 to \>8
      Tigecycline                                               100.0[^*a*^](#T2F1){ref-type="table-fn"}                                                                                    100.0                                                                               0.06     0.06     ≤0.015 to 0.5
      Trimethoprim-sulfamethoxazole                             97.9                                                                                                                        97.9                                                                                ≤0.5     ≤0.5     ≤0.5 to \>4
      Vancomycin                                                100.0                                                                                                                       100.0                                                                               1        1        0.5 to 2
  MS-CoNS (75)                                                                                                                                                                                                                                                                                    
      Delafloxacin                                                                                                                                                                                                                                                              ≤0.004   0.06     ≤0.004 to 1
      Levofloxacin                                              88.0                                                                                                                        88.0                                                                                0.25     4        ≤0.12 to \>4
      Ceftaroline                                                                                                                                                                                                                                                               0.12     0.25     0.03 to 0.5
      Clindamycin                                               84.0                                                                                                                        84.0                                                                                ≤0.25    \>2      ≤0.25 to \>2
      Daptomycin                                                100.0                                                                                                                       100.0                                                                               0.25     0.5      ≤0.06 to 1
      Erythromycin                                              69.3                                                                                                                        69.3                                                                                ≤0.12    \>16     ≤0.12 to \>16
      Linezolid                                                 100.0                                                                                                                       100.0                                                                               0.5      0.5      0.25to1
      Oxacillin                                                 100.0                                                                                                                       100.0                                                                               ≤0.25    1        ≤0.25 to 2
      Tetracycline                                              89.3                                                                                                                        86.7                                                                                ≤0.5     8        ≤0.5 to \>8
      Tigecycline                                                                                                                                                                           100.0                                                                               0.03     0.06     ≤0.015 to 0.12
      Trimethoprim-sulfamethoxazole                             92.0                                                                                                                        92.0                                                                                ≤0.5     ≤0.5     ≤0.5 to \>4
      Vancomycin                                                100.0                                                                                                                       100.0                                                                               1        2        0.25 to 4
  MR-CoNS (125)                                                                                                                                                                                                                                                                                   
      Delafloxacin                                                                                                                                                                                                                                                              0.06     0.5      ≤0.004 to 2
      Levofloxacin                                              38.4                                                                                                                        38.4                                                                                4        \>4      ≤0.12 to \>4
      Ceftaroline                                                                                                                                                                                                                                                               0.5      1        0.06 to 2
      Clindamycin                                               70.4                                                                                                                        67.2                                                                                ≤0.25    \>2      ≤0.25 to \>2
      Daptomycin                                                99.2                                                                                                                        99.2                                                                                0.5      0.5      ≤0.06 to 2
      Erythromycin                                              25.6                                                                                                                        25.6                                                                                \>16     \>16     ≤0.12 to \>16
      Linezolid                                                 100.0                                                                                                                       100.0                                                                               0.5      0.5      ≤0.12 to 1
      Oxacillin                                                 0.0                                                                                                                         0.0                                                                                 \>2      \>2      0.5 to \>2
      Tetracycline                                              80.8                                                                                                                        77.6                                                                                1        \>8      ≤0.5 to \>8
      Tigecycline                                                                                                                                                                           100.0                                                                               0.06     0.12     ≤0.015 to 0.25
      Trimethoprim-sulfamethoxazole                             65.6                                                                                                                        65.6                                                                                ≤0.5     \>4      ≤0.5 to \>4
      Vancomycin                                                100.0                                                                                                                       100.0                                                                               1        2        0.5 to 2
  Enterococcus faecalis (450)                                                                                                                                                                                                                                                                     
      Delafloxacin                                                                                                                                                                                                                                                              0.06     1        ≤0.004 to 2
      Levofloxacin                                              70.7                                                                                                                        70.7[^*b*^](#T2F2){ref-type="table-fn"}                                             1        \>4      0.25 to \>4
      Ampicillin                                                100.0                                                                                                                       99.6                                                                                1        2        ≤0.25 to 8
      Ceftaroline                                                                                                                                                                                                                                                               2        8        0.25 to \>32
      Clindamycin                                                                                                                                                                                                                                                               \>2      \>2      ≤0.25 to \>2
      Daptomycin                                                100.0                                                                                                                                                                                                           1        2        0.12 to 4
      Erythromycin                                              4.7                                                                                                                                                                                                             \>16     \>16     ≤0.12 to \>16
      Linezolid                                                 99.8                                                                                                                        100.0                                                                               1        1        ≤0.12 to 4
      Teicoplanin                                               97.8                                                                                                                        97.6                                                                                ≤2       ≤2       ≤2 to \>16
      Tetracycline                                              23.1                                                                                                                                                                                                            \>8      \>8      ≤0.5 to \>8
      Trimethoprim-sulfamethoxazole                                                                                                                                                                                                                                             ≤0.5     ≤0.5     ≤0.5 to \>4
      Vancomycin                                                97.8                                                                                                                        97.8                                                                                1        2        0.5 to \>16
  Enterococcus faecium (295)                                                                                                                                                                                                                                                                      
      Delafloxacin                                                                                                                                                                                                                                                              \>4      \>4      0.008 to \>4
      Levofloxacin                                              7.8                                                                                                                         10.8[^*b*^](#T2F2){ref-type="table-fn"}                                             \>4      \>4      0.5 to \>4
      Ampicillin                                                10.8                                                                                                                        10.8                                                                                \>8      \>8      ≤0.25 to \>8
      Ceftaroline                                                                                                                                                                                                                                                               \>32     \>32     0.12 to \>32
      Clindamycin                                                                                                                                                                                                                                                               \>2      \>2      ≤0.25 to \>2
      Daptomycin                                                99.0                                                                                                                                                                                                            2        4        0.12 to 8
      Erythromycin                                              3.7                                                                                                                                                                                                             \>16     \>16     ≤0.12 to \>16
      Linezolid                                                 99.0                                                                                                                        100.0                                                                               1        1        0.25 to 4
      Teicoplanin                                               47.1                                                                                                                        46.1                                                                                16       \>16     ≤2 to \>16
      Tetracycline                                              33.2                                                                                                                                                                                                            \>8      \>8      ≤0.5 to \>8
      Trimethoprim-sulfamethoxazole                                                                                                                                                                                                                                             ≤0.5     \>4      ≤0.5 to \>4
      Vancomycin                                                43.4                                                                                                                        43.4                                                                                \>16     \>16     0.25 to \>16
  Streptococcus pneumoniae (450)                                                                                                                                                                                                                                                                  
      Delafloxacin                                                                                                                                                                                                                                                              0.008    0.015    ≤0.004 to 0.25
      Levofloxacin                                              98.9                                                                                                                        98.9                                                                                1        1        0.5 to \>4
      Amoxicillin-clavulanic acid                               91.1                                                                                                                                                                                                            ≤1       2        ≤1 to \>8
      Ceftaroline                                               99.6[^*c*^](#T2F3){ref-type="table-fn"}                                                                                     99.3                                                                                ≤0.015   0.12     ≤0.015 to 1
      Ceftriaxone                                               83.6,[^*d*^](#T2F4){ref-type="table-fn"} 94.2[^*c*^](#T2F3){ref-type="table-fn"}                                            83.6                                                                                ≤0.06    1        ≤0.06 to 8
      Clindamycin                                               84.7                                                                                                                        84.9                                                                                ≤0.25    \>2      ≤0.25 to \>2
      Erythromycin                                              59.9                                                                                                                        59.9                                                                                ≤0.12    \>16     ≤0.12 to \>16
      Meropenem                                                 84.4                                                                                                                        84.4,[^*d*^](#T2F4){ref-type="table-fn"} 100.0[^*c*^](#T2F3){ref-type="table-fn"}   ≤0.015   0.5      ≤0.015 to 2
      Moxifloxacin                                              98.9                                                                                                                        98.7                                                                                ≤0.12    0.25     ≤0.12 to 2
      Penicillin                                                63.8,[^*e*^](#T2F5){ref-type="table-fn"} 63.8,[^*f*^](#T2F6){ref-type="table-fn"} 94.4[^*g*^](#T2F7){ref-type="table-fn"}   63.8,[^*d*^](#T2F4){ref-type="table-fn"} 63.8[^*g*^](#T2F7){ref-type="table-fn"}    ≤0.06    2        ≤0.06 to 8
      Tetracycline                                              78.4                                                                                                                        78.4                                                                                ≤0.5     \>8      ≤0.5 to \>8
      Trimethoprim-sulfamethoxazole                             68.9                                                                                                                        75.3                                                                                ≤0.5     \>4      ≤0.5 to \>4
  Viridans group streptococci (294)                                                                                                                                                                                                                                                               
      Delafloxacin                                                                                                                                                                                                                                                              0.015    0.03     ≤0.004 to 2
      Levofloxacin                                              94.1                                                                                                                                                                                                            1        2        ≤0.12 to \>4
      Amoxicillin-clavulanic acid                                                                                                                                                           79.7                                                                                ≤1       2        ≤1 to \>8
      Ceftaroline                                                                                                                                                                                                                                                               0.03     0.12     ≤0.015 to 1
      Ceftriaxone                                               90.9                                                                                                                        86.4                                                                                0.25     1        ≤0.06 to \>8
      Clindamycin                                               89.5                                                                                                                        89.9                                                                                ≤0.25    \>2      ≤0.25 to \>2
      Erythromycin                                              53.0                                                                                                                                                                                                            ≤0.12    8        ≤0.12 to \>16
      Meropenem                                                 93.7                                                                                                                        99.0                                                                                0.06     0.25     ≤0.015 to 4
      Moxifloxacin                                                                                                                                                                                                                                                              ≤0.12    0.25     ≤0.12 to \>4
      Penicillin                                                73.1                                                                                                                        79.7                                                                                ≤0.06    1        ≤0.06 to \>8
      Tetracycline                                              64.3                                                                                                                                                                                                            ≤0.5     \>8      ≤0.5 to \>8
      Trimethoprim-sulfamethoxazole                                                                                                                                                                                                                                             ≤0.5     4        ≤0.5 to \>4
  Streptococcus pyogenes (433)                                                                                                                                                                                                                                                                    
      Delafloxacin                                                                                                                                                                                                                                                              0.008    0.015    ≤0.004 to 0.03
      Levofloxacin                                              99.8                                                                                                                        96.5                                                                                0.5      1        0.25 to \>4
      Amoxicillin-clavulanic acid                               100.0                                                                                                                       100.0                                                                               ≤1       ≤1       ≤1 to ≤1
      Ceftaroline                                               100.0                                                                                                                       100.0                                                                               ≤0.015   ≤0.015   ≤0.015 to 0.03
      Ceftriaxone                                               100.0                                                                                                                       100.0                                                                               ≤0.06    ≤0.06    ≤0.06 to 0.5
      Clindamycin                                               91.5                                                                                                                        91.9                                                                                ≤0.25    ≤0.25    ≤0.25 to \>2
      Erythromycin                                              85.2                                                                                                                        85.2                                                                                ≤0.12    \>16     ≤0.12 to \>16
      Meropenem                                                 100.0                                                                                                                       100.0                                                                               ≤0.015   ≤0.015   ≤0.015 to 0.12
      Moxifloxacin                                                                                                                                                                          100.0                                                                               ≤0.12    0.25     ≤0.12 to 0.5
      Penicillin                                                100.0                                                                                                                       100.0                                                                               ≤0.06    ≤0.06    ≤0.06 to 0.12
      Tetracycline                                              80.2                                                                                                                        78.6                                                                                ≤0.5     \>8      ≤0.5 to \>8
      Vancomycin                                                100.0                                                                                                                       100.0                                                                               0.25     0.5      ≤0.12 to 0.5
  Streptococcus agalactiae (225)                                                                                                                                                                                                                                                                  
      Delafloxacin                                                                                                                                                                                                                                                              0.008    0.015    ≤0.004 to 0.5
      Levofloxacin                                              97.8                                                                                                                        96.9                                                                                0.5      1        0.25 to \>4
      Amoxicillin-clavulanic acid                               100.0                                                                                                                       100.0                                                                               ≤1       ≤1       ≤1 to ≤1
      Ceftaroline                                               100.0                                                                                                                       100.0                                                                               ≤0.015   0.03     ≤0.015 to 0.03
      Ceftriaxone                                               100.0                                                                                                                       100.0                                                                               ≤0.06    0.12     ≤0.06 to 0.25
      Clindamycin                                               70.7                                                                                                                        72.4                                                                                ≤0.25    \>2      ≤0.25 to \>2
      Erythromycin                                              52.4                                                                                                                        52.4                                                                                ≤0.12    \>16     ≤0.12 to \>16
      Meropenem                                                 100.0                                                                                                                       100.0                                                                               0.03     0.06     ≤0.015 to 0.12
      Moxifloxacin                                                                                                                                                                          97.8                                                                                ≤0.12    0.25     ≤0.12 to \>4
      Penicillin                                                100.0                                                                                                                       100.0                                                                               ≤0.06    ≤0.06    ≤0.06 to ≤0.06
      Tetracycline                                              17.4                                                                                                                        17.0                                                                                \>8      \>8      ≤0.5 to \>8
      Vancomycin                                                100.0                                                                                                                       100.0                                                                               0.5      0.5      0.25 to 1
  Streptococcus dysgalactiae (132)                                                                                                                                                                                                                                                                
      Delafloxacin                                                                                                                                                                                                                                                              0.008    0.015    ≤0.004 to 0.03
      Levofloxacin                                              99.2                                                                                                                        97.0                                                                                0.5      1        0.25 to \>4
      Amoxicillin-clavulanic acid                               100.0                                                                                                                       100.0                                                                               ≤1       ≤1       ≤1 to ≤1
      Ceftaroline                                               100.0                                                                                                                       100.0                                                                               ≤0.015   ≤0.015   ≤0.015 to ≤0.015
      Ceftriaxone                                               100.0                                                                                                                       100.0                                                                               ≤0.06    ≤0.06    ≤0.06 to 0.5
      Clindamycin                                               88.6                                                                                                                        90.2                                                                                ≤0.25    0.5      ≤0.25 to \>2
      Erythromycin                                              68.9                                                                                                                        68.9                                                                                ≤0.12    \>16     ≤0.12 to \>16
      Meropenem                                                 100.0                                                                                                                       100.0                                                                               ≤0.015   ≤0.015   ≤0.015 to 0.06
      Moxifloxacin                                                                                                                                                                          100.0                                                                               ≤0.12    0.25     ≤0.12 to 0.25
      Penicillin                                                100.0                                                                                                                       100.0                                                                               ≤0.06    ≤0.06    ≤0.06 to ≤0.06
      Tetracycline                                              61.8                                                                                                                        59.5                                                                                ≤0.5     \>8      ≤0.5 to \>8
      Vancomycin                                                100.0                                                                                                                       100.0                                                                               0.25     0.25     ≤0.12 to 1

Breakpoints from FDA package insert, revised December 2014.

Uncomplicated UTI only.

Using nonmeningitis breakpoints.

Using meningitis breakpoints.

Using oral breakpoints.

Using parenteral, meningitis breakpoints.

Using parenteral, nonmeningitis breakpoints.

The delafloxacin MIC~50~ and MIC~90~ values for all coagulase-negative staphylococci (CoNS) were 0.008 and 0.5 μg/ml, respectively ([Table 1](#T1){ref-type="table"}). Tigecycline (MIC~50~ and MIC~90~, 0.03 and 0.06 μg/ml, respectively) and delafloxacin (MIC~50~ and MIC~90~, ≤0.004 and 0.06 μg/ml, respectively) were the most potent agents tested against MS-CoNS ([Table 2](#T2){ref-type="table"}). When delafloxacin was tested against isolates of MS-CoNS, it was 4-fold more potent than ceftaroline, 8-fold more potent than linezolid, 32-fold more potent than vancomycin, and \>64-fold more potent than levofloxacin (according to the MIC~90~s). European isolates of MS-CoNS were more susceptible than U.S. isolates to levofloxacin (97.0% versus 81.0%, respectively), clindamycin (90.9% versus 78.6%, respectively), erythromycin (72.7% versus 66.7%, respectively), tetracycline (93.9% versus 85.7%, respectively), and trimethoprim-sulfamethoxazole (100.0% versus 85.7%, respectively) (data not shown).

The antibiogram results for MR-CoNS isolates from both Europe (67 isolates) and the United States (58 isolates) showed higher MIC values for all tested drugs except daptomycin (to which 99.2% of isolates were susceptible), linezolid (to which 100.0% of isolates were susceptible), and vancomycin (to which 100.0% of isolates were susceptible). Tigecycline (MIC~50~ and MIC~90~, 0.06 and 0.12 μg/ml, respectively), delafloxacin (MIC~50~ and MIC~90~, 0.06 and 0.5 μg/ml, respectively), linezolid (MIC~50~ and MIC~90~, 0.5 and 0.5 μg/ml, respectively), and ceftaroline (MIC~50~ and MIC~90~, 0.5 and 1 μg/ml, respectively) were the most potent antimicrobials tested against both European and U.S. strains of MR-CoNS. Levofloxacin, clindamycin, erythromycin, and trimethoprim-sulfamethoxazole all showed limited activity against MR-CoNS isolates from both regions.

All isolates of E. faecalis from Europe and the United States were susceptible to ampicillin ([Table 2](#T2){ref-type="table"}). A small number of E. faecalis strains were resistant to vancomycin (2.2%). Delafloxacin (MIC~50~ and MIC~90~, 0.06 and 1 μg/ml, respectively) and linezolid (MIC~50~ and MIC~90~, 1 and 1 μg/ml, respectively) were the most potent antimicrobials tested ([Table 2](#T2){ref-type="table"}).

Delafloxacin (MIC~50~ and MIC~90~, \>4 and \>4 μg/ml, respectively; 10.5% of isolates were susceptible to delafloxacin at ≤1 μg/ml), levofloxacin (MIC~50~ and MIC~90~, \>4 and \>4 μg/ml, respectively; 7.8 and 10.8% of isolates were susceptible according to CLSI and EUCAST criteria, respectively), erythromycin (MIC~50~ and MIC~90~, \>16 and \>16 μg/ml, respectively; 3.7% of isolates were susceptible according to the CLSI criterion), and ampicillin (MIC~50~ and MIC~90~, \>8 and \>8 μg/ml, respectively; 10.8 and 10.8% of isolates were susceptible according to CLSI and EUCAST criteria, respectively) displayed limited activity against E. faecium strains regardless of geographic region or vancomycin susceptibility patterns ([Table 2](#T2){ref-type="table"}).

Delafloxacin was the most active agent tested against S. pneumoniae isolates from Europe and the United States (MIC~50~ and MIC~90~, 0.008 and 0.015 μg/ml, respectively) ([Table 2](#T2){ref-type="table"}). All European isolates (100.0%) and 98.0% of U.S. isolates were inhibited by ≤0.03 μg/ml of delafloxacin; the highest delafloxacin MIC value for U.S. isolates was 0.25 μg/ml ([Table 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). Delafloxacin was 8-fold more active than ceftaroline (MIC~50~ and MIC~90~, ≤0.015 and 0.12 μg/ml, respectively), 16-fold more active than moxifloxacin (MIC~50~ and MIC~90~, ≤0.12 and 0.25 μg/ml, respectively), and 64-fold more active than levofloxacin (MIC~50~ and MIC~90~, 1 and 1 μg/ml, respectively) ([Table 2](#T2){ref-type="table"}). For other common-use antimicrobials, the rate of penicillin resistance (MIC, ≥2 μg/ml, oral breakpoint) was 11.3% (0.7%; MIC, ≥8 μg/ml, parenteral, nonmeningitis breakpoint), the rate of erythromycin resistance was 39.0%, the rate of tetracycline resistance was 21.6%, and the rate of trimethoprim-sulfamethoxazole resistance was 18.9% ([Table 2](#T2){ref-type="table"}). The delafloxacin MIC for the three high-level penicillin-resistant (MIC, \>4 μg/ml) strains was 0.008 μg/ml (data not shown).

The most active agents tested against the viridans group streptococci were delafloxacin (MIC~50~ and MIC~90~, 0.015 and 0.03 μg/ml; [Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}), moxifloxacin (MIC~50~ and MIC~90~, ≤0.12 and 0.25 μg/ml, respectively), and ceftaroline (MIC~50~ and MIC~90~, 0.03 and 0.12 μg/ml, respectively) ([Table 2](#T2){ref-type="table"}). The rate of resistance to penicillin and ceftriaxone was higher among European isolates (11.2% and 12.2%, respectively) than U.S. isolates (2.6 and 3.1%, respectively). The rates of resistance to levofloxacin and erythromycin were comparable for European isolates (5.1% and 44.9%, respectively) and U.S. isolates (5.6% and 44.6%, respectively) ([Table 2](#T2){ref-type="table"}). Meropenem exhibited the highest coverage against viridans group streptococci and was more active against U.S. isolates (96.4 and 100.0% of isolates were susceptible according to CLSI and EUCAST criteria, respectively) than European isolates (88.8 and 96.9% of isolates were susceptible according to CLSI and EUCAST criteria, respectively).

The activities of delafloxacin and comparator antimicrobial agents against a total of 790 isolates of beta-hemolytic streptococci (433 isolates of Streptococcus pyogenes, 225 of Streptococcus agalactiae, and 132 of Streptococcus dysgalactiae) were tested ([Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). Delafloxacin was highly potent against these organisms ([Table 1](#T1){ref-type="table"}). All delafloxacin MIC values for S. pyogenes and S. dysgalactiae were ≤0.03 μg/ml. The highest delafloxacin MIC value for S. agalactiae was 0.5 μg/ml, and 97.3% of S. agalactiae isolates were inhibited by delafloxacin at ≤0.03 μg/ml ([Table 1](#T1){ref-type="table"}). All beta-hemolytic streptococcal isolates were susceptible to ceftaroline, ceftriaxone, meropenem, penicillin, and vancomycin ([Table 2](#T2){ref-type="table"}). The rates of resistance to levofloxacin were 0.2% for S. pyogenes, 2.2% for S. agalactiae, and 0.8% for S. dysgalactiae ([Table 2](#T2){ref-type="table"}). The rate of resistance to erythromycin was higher among isolates of S. agalactiae (46.7%) and S. dysgalactiae (29.5%) than among isolates of S. pyogenes (14.1%). The rate of resistance to clindamycin among isolates of beta-hemolytic streptococci ranged from 8.1% to 27.6% ([Table 2](#T2){ref-type="table"}).

Susceptibilities of European and U.S. Gram-negative isolates to delafloxacin and comparator agents. {#sec2-3}
---------------------------------------------------------------------------------------------------

Delafloxacin was active against the majority of the Enterobacteriaceae, exhibiting MIC~50~ and MIC~90~ values of 0.06 and 4 μg/ml, respectively, and with 80.9% of isolates being inhibited by delafloxacin at ≤1 μg/ml ([Table 1](#T1){ref-type="table"}). The rates of susceptibility to fluoroquinolones, as measured by the use of ciprofloxacin and levofloxacin, for the Enterobacteriaceae were 81.6% and 83.8%, respectively ([Table 3](#T3){ref-type="table"}). More than 90% of FQ^r^ Enterobacteriaceae isolates showed decreased susceptibility (MIC, \>1 μg/ml) to delafloxacin (data not shown). The rates of susceptibility to aztreonam, ceftriaxone, cefepime, and ceftazidime ranged from 80.3% to 90.8% ([Table 3](#T3){ref-type="table"}). Meropenem (MIC~50~ and MIC~90~, 0.03 and 0.06 μg/ml, respectively; 97.5 and 97.9% of isolates were susceptible according to CLSI and EUCAST criteria, respectively) and tigecycline (MIC~50~ and MIC~90~, 0.25 and 1 μg/ml, respectively; 99.2 and 95.2% of isolates were susceptible according to CLSI and EUCAST criteria, respectively) were the most active agents ([Table 3](#T3){ref-type="table"}).

###### 

Activity of delafloxacin and comparator antimicrobial agents when tested against U.S. and European Gram-negative isolates

  Organism group (no. of isolates tested)/antimicrobial agent   \% of isolates susceptible by the following criteria:   MIC (μg/ml)                    
  ------------------------------------------------------------- ------------------------------------------------------- ------------- -------- ------- ----------------
  Enterobacteriaceae (2,250)                                                                                                                           
      Delafloxacin                                                                                                                    0.06     4       ≤0.004 to \>4
      Levofloxacin                                              83.8                                                    81.9          ≤0.12    \>4     ≤0.12 to \>4
      Ampicillin-sulbactam                                      47.4                                                    47.4          16       \>32    0.5 to \>32
      Aztreonam                                                 86.3                                                    83.6          ≤0.12    \>16    ≤0.12 to \>16
      Cefepime                                                  90.8                                                    87.8          ≤0.5     2       ≤0.5 to \>16
      Ceftazidime                                               86.3                                                    82.8          0.25     16      0.03 to \>32
      Ceftriaxone                                               80.3                                                    80.3          0.12     \>8     ≤0.06 to \>8
      Ciprofloxacin                                             81.6                                                    79.3          ≤0.03    \>4     ≤0.03 to \>4
      Gentamicin                                                90.7                                                    89.0          ≤1       4       ≤1 to \>8
      Meropenem                                                 97.5                                                    97.9          0.03     0.06    ≤0.015 to \>32
      Piperacillin-tazobactam                                   89.3                                                    85.7          2        32      ≤0.5 to \>64
      Tigecycline                                               99.2[^*b*^](#T3F2){ref-type="table-fn"}                 95.2          0.25     1       0.03 to 4
  Escherichia coli (500)                                                                                                                               
      Delafloxacin                                                                                                                    0.03     4       ≤0.004 to \>4
      Levofloxacin                                              69.6                                                    69.6          ≤0.12    \>4     ≤0.12 to \>4
      Ampicillin-sulbactam                                      49.6                                                    49.6          16       \>32    0.5 to \>32
      Aztreonam                                                 86.4                                                    82.6          ≤0.12    16      ≤0.12 to \>16
      Cefepime                                                  87.0                                                    84.2          ≤0.5     8       ≤0.5 to \>16
      Ceftazidime                                               89.2                                                    83.4          0.12     8       0.03 to \>32
      Ceftriaxone                                               84.0                                                    84.0          ≤0.06    \>8     ≤0.06 to \>8
      Ciprofloxacin                                             69.4                                                    68.8          ≤0.03    \>4     ≤0.03 to \>4
      Gentamicin                                                86.4                                                    86.0          ≤1       \>8     ≤1 to \>8
      Meropenem                                                 99.6                                                    99.6          ≤0.015   0.03    ≤0.015 to 4
      Piperacillin-tazobactam                                   94.2                                                    90.0          2        8       ≤0.5 to \>64
      Tigecycline                                               100.0[^*b*^](#T3F2){ref-type="table-fn"}                100.0         0.06     0.12    0.03 to 1
  E. coli isolates of the ESBL phenotype (92)                                                                                                          
      Delafloxacin                                                                                                                    2        \>4     0.008 to \>4
      Levofloxacin                                              21.7                                                    21.7          \>4      \>4     ≤0.12 to \>4
      Ampicillin-sulbactam                                      16.3                                                    16.3          32       \>32    2 to \>32
      Aztreonam                                                 26.1                                                    5.4           \>16     \>16    ≤0.12 to \>16
      Cefepime                                                  31.5                                                    20.7          16       \>16    ≤0.5 to \>16
      Ceftazidime                                               41.3                                                    9.8           8        32      0.06 to \>32
      Ceftriaxone                                               13.0                                                    13.0          \>8      \>8     0.25 to \>8
      Ciprofloxacin                                             20.7                                                    19.6          \>4      \>4     ≤0.03 to \>4
      Gentamicin                                                63.0                                                    62.0          ≤1       \>8     ≤1 to \>8
      Meropenem                                                 97.8                                                    97.8          ≤0.015   0.03    ≤0.015 to 4
      Piperacillin-tazobactam                                   81.5                                                    65.2          8        \>64    1 to \>64
      Tigecycline                                               100.0[^*b*^](#T3F2){ref-type="table-fn"}                100.0         0.12     0.12    0.06 to 0.5
  Klebsiella pneumoniae (389)                                                                                                                          
      Delafloxacin                                                                                                                    0.06     \>4     0.015 to \>4
      Levofloxacin                                              81.5                                                    80.2          ≤0.12    \>4     ≤0.12 to \>4
      Ampicillin-sulbactam                                      63.2                                                    63.2          8        \>32    1 to \>32
      Aztreonam                                                 77.1                                                    75.8          ≤0.12    \>16    ≤0.12 to \>16
      Cefepime                                                  77.9[^*a*^](#T3F1){ref-type="table-fn"}                 75.3          ≤0.5     \>16    ≤0.5 to \>16
      Ceftazidime                                               76.9                                                    74.8          0.12     \>32    0.03 to \>32
      Ceftriaxone                                               75.3                                                    75.3          ≤0.06    \>8     ≤0.06 to \>8
      Ciprofloxacin                                             77.4                                                    75.6          ≤0.03    \>4     ≤0.03 to \>4
      Gentamicin                                                86.4                                                    85.1          ≤1       \>8     ≤1 to \>8
      Meropenem                                                 90.2                                                    91.0          0.03     1       ≤0.015 to \>32
      Piperacillin-tazobactam                                   81.2                                                    75.8          4        \>64    ≤0.5 to \>64
      Tigecycline                                               99.7[^*b*^](#T3F2){ref-type="table-fn"}                 97.7          0.25     0.5     0.06 to 4
  K. pneumoniae isolates of the ESBL phenotype (102)                                                                                                   
      Delafloxacin                                                                                                                    4        \>4     0.06 to \>4
      Levofloxacin                                              34.3                                                    32.4          \>4      \>4     ≤0.12 to \>4
      Ampicillin-sulbactam                                      1.0                                                     1.0           \>32     \>32    4 to \>32
      Aztreonam                                                 12.7                                                    7.8           \>16     \>16    ≤0.12 to \>16
      Cefepime                                                  15.7                                                    5.9           \>16     \>16    ≤0.5 to \>16
      Ceftazidime                                               11.8                                                    3.9           \>32     \>32    0.25 to \>32
      Ceftriaxone                                               5.9                                                     5.9           \>8      \>8     0.12 to \>8
      Ciprofloxacin                                             18.6                                                    15.7          \>4      \>4     ≤0.03 to \>4
      Gentamicin                                                48.0                                                    43.1          \>8      \>8     ≤1 to \>8
      Meropenem                                                 62.7                                                    65.7          0.06     \>32    ≤0.015 to \>32
      Piperacillin-tazobactam                                   31.4                                                    23.5          \>64     \>64    2 to \>64
      Tigecycline                                               99.0[^*b*^](#T3F2){ref-type="table-fn"}                 96.1          0.25     0.5     0.12 to 4
  Klebsiella oxytoca (111)                                                                                                                             
      Delafloxacin                                                                                                                    0.06     0.12    0.03 to 1
      Levofloxacin                                              100.0                                                   100.0         ≤0.12    ≤0.12   ≤0.12 to 1
      Ampicillin-sulbactam                                      63.1                                                    63.1          8        \>32    2 to \>32
      Aztreonam                                                 83.8                                                    81.1          0.25     \>16    ≤0.12 to \>16
      Cefepime                                                  98.2[^*a*^](#T3F1){ref-type="table-fn"}                 96.4          ≤0.5     1       ≤0.5 to \>16
      Ceftazidime                                               98.2                                                    97.3          0.12     0.5     0.03 to \>32
      Ceftriaxone                                               82.9                                                    82.9          0.12     \>8     ≤0.06 to \>8
      Ciprofloxacin                                             98.2                                                    98.2          ≤0.03    0.06    ≤0.03 to 4
      Gentamicin                                                99.1                                                    99.1          ≤1       ≤1      ≤1 to \>8
      Meropenem                                                 100.0                                                   100.0         0.03     0.03    ≤0.015 to 0.06
      Piperacillin-tazobactam                                   81.1                                                    78.4          2        \>64    ≤0.5 to \>64
      Tigecycline                                               100.0[^*b*^](#T3F2){ref-type="table-fn"}                100.0         0.12     0.25    0.06 to 1
  Proteus mirabilis (211)                                                                                                                              
      Delafloxacin                                                                                                                    0.06     2       0.015 to \>4
      Levofloxacin                                              78.7                                                    71.1          ≤0.12    \>4     ≤0.12 to \>4
      Ampicillin-sulbactam                                      86.7                                                    86.7          2        16      0.5 to \>32
      Aztreonam                                                 99.5                                                    98.1          ≤0.12    ≤0.12   ≤0.12 to 8
      Cefepime                                                  97.2[^*a*^](#T3F1){ref-type="table-fn"}                 96.7          ≤0.5     ≤0.5    ≤0.5 to \>16
      Ceftazidime                                               97.2                                                    94.3          0.06     0.12    0.03 to 32
      Ceftriaxone                                               93.4                                                    93.4          ≤0.06    ≤0.06   ≤0.06 to \>8
      Ciprofloxacin                                             71.6                                                    67.8          ≤0.03    \>4     ≤0.03 to \>4
      Gentamicin                                                88.6                                                    85.3          ≤1       8       ≤1 to \>8
      Meropenem                                                 100.0                                                   100.0         0.06     0.12    ≤0.015 to 1
      Piperacillin-tazobactam                                   100.0                                                   100.0         ≤0.5     1       ≤0.5 to 8
      Tigecycline                                               94.3[^*b*^](#T3F2){ref-type="table-fn"}                 64.5          1        2       0.12 to 4
  Enterobacter spp. (384)                                                                                                                              
      Delafloxacin                                                                                                                    0.06     1       ≤0.004 to \>4
      Levofloxacin                                              96.6                                                    95.8          ≤0.12    0.5     ≤0.12 to \>4
      Ampicillin-sulbactam                                      24.1                                                    24.1          32       \>32    0.5 to \>32
      Aztreonam                                                 76.6                                                    73.7          ≤0.12    \>16    ≤0.12 to \>16
      Cefepime                                                  93.7[^*a*^](#T3F1){ref-type="table-fn"}                 85.6          ≤0.5     2       ≤0.5 to \>16
      Ceftazidime                                               75.7                                                    73.0          0.25     \>32    0.03 to \>32
      Ceftriaxone                                               70.6                                                    70.6          0.25     \>8     ≤0.06 to \>8
      Ciprofloxacin                                             95.5                                                    94.5          ≤0.03    0.25    ≤0.03 to \>4
      Gentamicin                                                96.9                                                    96.9          ≤1       ≤1      ≤1 to \>8
      Meropenem                                                 97.9                                                    99.0          0.03     0.06    ≤0.015 to \>32
      Piperacillin-tazobactam                                   81.2                                                    77.2          2        64      ≤0.5 to \>64
      Tigecycline                                               100.0[^*b*^](#T3F2){ref-type="table-fn"}                97.6          0.25     0.25    0.03 to 2
  Citrobacter spp. (178)                                                                                                                               
      Delafloxacin                                                                                                                    0.06     2       0.008 to \>4
      Levofloxacin                                              93.8                                                    92.7          ≤0.12    0.5     ≤0.12 to \>4
      Ampicillin-sulbactam                                      68.5                                                    68.5          4        \>32    1 to \>32
      Aztreonam                                                 89.3                                                    87.1          ≤0.12    16      ≤0.12 to \>16
      Cefepime                                                  97.2                                                    94.9          ≤0.5     ≤0.5    ≤0.5 to \>16
      Ceftazidime                                               87.6                                                    86.0          0.25     16      0.06 to \>32
      Ceftriaxone                                               87.1                                                    87.1          0.12     \>8     ≤0.06 to \>8
      Ciprofloxacin                                             92.1                                                    91.0          ≤0.03    0.5     ≤0.03 to \>4
      Gentamicin                                                95.5                                                    94.4          ≤1       ≤1      ≤1 to \>8
      Meropenem                                                 97.8                                                    98.3          ≤0.015   0.03    ≤0.015 to 8
      Piperacillin-tazobactam                                   90.4                                                    85.4          2        16      ≤0.5 to \>64
      Tigecycline                                               100.0[^*b*^](#T3F2){ref-type="table-fn"}                99.4          0.12     0.25    0.06 to 2
  Indole-positive Proteus spp. (249)                                                                                                                   
      Delafloxacin                                                                                                                    0.12     4       0.008 to \>4
      Levofloxacin                                              75.2                                                    70.0          ≤0.12    \>4     ≤0.12 to \>4
      Ampicillin-sulbactam                                      29.6                                                    29.6          16       32      0.5 to \>32
      Aztreonam                                                 96.0                                                    92.0          ≤0.12    1       ≤0.12 to \>16
      Cefepime                                                  95.2[^*a*^](#T3F1){ref-type="table-fn"}                 94.0          ≤0.5     ≤0.5    ≤0.5 to \>16
      Ceftazidime                                               87.2                                                    82.0          0.12     16      0.03 to \>32
      Ceftriaxone                                               75.6                                                    75.6          ≤0.06    8       ≤0.06 to \>8
      Ciprofloxacin                                             73.6                                                    66.8          ≤0.03    \>4     ≤0.03 to \>4
      Gentamicin                                                85.8                                                    77.6          ≤1       8       ≤1 to \>8
      Meropenem                                                 100.0                                                   100.0         0.06     0.12    ≤0.015 to 1
      Piperacillin-tazobactam                                   95.2                                                    94.0          ≤0.5     4       ≤0.5 to \>64
      Tigecycline                                               98.4[^*b*^](#T3F2){ref-type="table-fn"}                 95.2          0.5      1       0.12 to 4
  Serratia spp. (193)                                                                                                                                  
      Delafloxacin                                                                                                                    1        2       0.03 to \>4
      Levofloxacin                                              95.9                                                    93.3          ≤0.12    1       ≤0.12 to \>4
      Ampicillin-sulbactam                                      5.2                                                     5.2           \>32     \>32    4 to \>32
      Aztreonam                                                 94.3                                                    90.7          ≤0.12    1       ≤0.12 to \>16
      Cefepime                                                  96.4[^*a*^](#T3F1){ref-type="table-fn"}                 94.8          ≤0.5     ≤0.5    ≤0.5 to \>16
      Ceftazidime                                               96.4                                                    93.3          0.25     1       0.03 to \>32
      Ceftriaxone                                               84.5                                                    84.5          0.25     4       ≤0.06 to \>8
      Ciprofloxacin                                             93.8                                                    87.6          0.12     1       ≤0.03 to \>4
      Gentamicin                                                96.4                                                    94.3          ≤1       2       ≤1 to \>8
      Meropenem                                                 97.3                                                    97.9          0.03     0.06    ≤0.015 to 8
      Piperacillin-tazobactam                                   92.7                                                    88.1          2        16      ≤0.5 to \>64
      Tigecycline                                               99.0[^*b*^](#T3F2){ref-type="table-fn"}                 98.4          0.5      0.5     0.06 to 4
  Pseudomonas aeruginosa (200)                                                                                                                         
      Delafloxacin                                                                                                                    0.25     \>4     0.015 to \>4
      Levofloxacin                                              72.5                                                    62.5          0.5      \>4     ≤0.12 to \>4
      Amikacin                                                  93.5                                                    89.5          2        16      ≤0.25 to \>32
      Aztreonam                                                 55.5                                                    3.5           8        \>16    0.25 to \>16
      Cefepime                                                  83.0                                                    83.0          2        16      ≤0.5 to \>16
      Ceftazidime                                               78.5                                                    78.5          2        \>32    0.25 to \>32
      Ceftriaxone                                                                                                                     \>8      \>8     1 to \>8
      Ciprofloxacin                                             75.0                                                    70.0          0.25     \>4     ≤0.03 to \>4
      Colistin                                                  98.5                                                    100.0         2        2       ≤0.5 to 4
      Gentamicin                                                85.5                                                    85.5          ≤1       \>8     ≤1 to \>8
      Meropenem                                                 74.4                                                    74.4          0.5      8       ≤0.015 to \>32
      Piperacillin-tazobactam                                   78.0                                                    78.0          8        \>64    ≤0.5 to \>64
  Acinetobacter baumannii-A. calcoaceticus (200)                                                                                                       
      Delafloxacin                                                                                                                    2        \>4     0.015 to \>4
      Levofloxacin                                              34.0                                                    33.0          \>4\>4           ≤0.12 to \>4
      Amikacin                                                  53.5                                                    51.0          8        \>32    1 to \>32
      Ampicillin-sulbactam                                      40.2                                                                  16       \>32    0.5 to \>32
      Aztreonam                                                                                                                       \>16     \>16    4 to \>16
      Cefepime                                                  36.0                                                                  \>16     \>16    ≤0.5 to \>16
      Ceftazidime                                               38.5                                                                  \>32     \>32    0.5 to \>32
      Ciprofloxacin                                             32.5                                                    32.5          \>4      \>4     0.06 to \>4
      Colistin                                                  92.0                                                    92.0          1        2       ≤0.5 to \>8
      Gentamicin                                                48.0                                                    48.0          8        \>8     ≤1 to \>8
      Meropenem                                                 41.2                                                    41.2          16       \>32    0.06 to \>32
      Piperacillin-tazobactam                                   35.2                                                                  \>64     \>64    ≤0.5 to \>64

Intermediate is interpreted as susceptible-dose dependent.

Breakpoints from the FDA package insert, revised December 2014.

Among ESBL-phenotype isolates of E. coli and K. pneumoniae, the potencies of all comparator agents were markedly decreased ([Table 3](#T3){ref-type="table"}). Meropenem (97.8 and 97.8% of isolates were susceptible according to CLSI and EUCAST criteria, respectively) retained potent activity against ESBL-phenotype strains of E. coli, whereas the rate of meropenem resistance was high (34.3 and 26.5% of isolates were susceptible according to CLSI and EUCAST criteria, respectively) among isolates of ESBL-producing K. pneumoniae ([Table 3](#T3){ref-type="table"}). ESBL-phenotype K. pneumoniae isolates remained susceptible to tigecycline (99.0 and 96.1% of isolates were susceptible according to CLSI and EUCAST criteria, respectively). Only 28.3% of ESBL-phenotype E. coli isolates and 18.6% of ESBL-phenotype K. pneumoniae isolates were inhibited by delafloxacin at ≤1 μg/ml ([Table 1](#T1){ref-type="table"}).

In contrast to the results observed with K. pneumoniae, the activity of delafloxacin was higher against K. oxytoca isolates (100.0% of K. oxytoca isolates but only 76.6% of K. pneumoniae isolates were inhibited by delafloxacin at ≤1 μg/ml; [Table 1](#T1){ref-type="table"}), including ESBL-phenotype strains ([Table 1](#T1){ref-type="table"}). The rates of susceptibility to ciprofloxacin, levofloxacin, cefepime, meropenem, gentamicin, and tigecycline for K. oxytoca were \>96.0% ([Table 3](#T3){ref-type="table"}), despite the inclusion of 22 ESBL-phenotype isolates.

Delafloxacin was active against species of Enterobacteriaceae with high rates of ceftazidime resistance due to AmpC β-lactamase production, including Enterobacter, Citrobacter, and Serratia isolates ([Tables 1](#T1){ref-type="table"} and [3](#T3){ref-type="table"}). Delafloxacin at ≤1 μg/ml inhibited 91.4% of Enterobacter spp. (87.4 and 92.7% of isolates from Europe and the United States, respectively). Delafloxacin MIC values were ≤1 μg/ml for 87.6% of Citrobacter spp. (88.3 and 87.3% of isolates from Europe and the United States, respectively) and 76.7% of Serratia spp. (73.8 and 78.0% of isolates from Europe and the United States, respectively) ([Table 1](#T1){ref-type="table"}). The rates of susceptibility of isolates of these three genera to ciprofloxacin, levofloxacin, cefepime, meropenem, and tigecycline were \>90.0% ([Table 3](#T3){ref-type="table"}). Proteus mirabilis and indole-positive Proteae were generally susceptible to aztreonam, cefepime, meropenem, and piperacillin-tazobactam but showed decreased susceptibility to the fluoroquinolones, including delafloxacin.

Among European and U.S. isolates of P. aeruginosa, only amikacin (93.5 and 89.5% of isolates were susceptible according to CLSI and EUCAST criteria, respectively) and colistin (98.5 and 100.0% of isolates were susceptible according to CLSI and EUCAST criteria, respectively) were active against \>90% of isolates tested ([Table 3](#T3){ref-type="table"}). Delafloxacin at ≤1 μg/ml inhibited 74.0% of P. aeruginosa isolates ([Table 1](#T1){ref-type="table"}). The rates of susceptibility to ciprofloxacin were 75.0 and 70.0% according to CLSI and EUCAST criteria, respectively, and the rates of susceptibility to levofloxacin were 72.5 and 62.5% according to CLSI and EUCAST criteria, respectively. Among 40 levofloxacin-resistant isolates of P. aeruginosa, delafloxacin MIC values were \>1 μg/ml for 39 isolates (data not shown). The rates of resistance to ceftazidime among isolates of P. aeruginosa were 16.5 and 21.5% according to CLSI and EUCAST criteria, respectively ([Table 3](#T3){ref-type="table"}). The susceptibility of ceftazidime-resistant P. aeruginosa isolates to all agents except colistin was poor (data not shown).

A. baumannii-A. calcoaceticus isolates were nonsusceptible (intermediate or resistant by CLSI and EUCAST criteria) to most agents tested ([Table 3](#T3){ref-type="table"}). Delafloxacin at ≤1 μg/ml inhibited 44.0% of isolates ([Table 1](#T1){ref-type="table"}). The rates of susceptibility to ciprofloxacin and levofloxacin were 32.5% and 34.0%, respectively ([Table 3](#T3){ref-type="table"}), and ranged from 48.0% to 50.0% for U.S. isolates and from 17.0% to 18.0% for European isolates (data not shown). Only the rate of susceptibility to colistin (MIC~50~ and MIC~90~, 1 and 2 μg/ml, respectively; 92.0 and 92.0% of isolates were susceptible according to CLSI and EUCAST criteria, respectively) achieved a value of \>90.0% ([Table 3](#T3){ref-type="table"}). In general, resistance to the tested agents was greater for European isolates than U.S. isolates of Acinetobacter.

Antibiotic resistance is a growing problem in both European and U.S. medical centers ([@B22]). Active surveillance and antimicrobial stewardship efforts are essential to combat this threat to patient safety across all health care settings ([@B23], [@B24]). In the present survey, we examined the *in vitro* susceptibility profiles of 6,485 isolates of GPC and GNB from European and U.S. medical centers for the year 2014. The data from the present survey document the comparable activity of delafloxacin against European and U.S. bacterial isolates. Overall, the broadest coverage of the tested pathogens was observed with meropenem and tigecycline in both Europe and the United States ([Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}). The most active agents against staphylococci and streptococci were delafloxacin, daptomycin, and tigecycline, whereas meropenem and tigecycline were the most active agents against GNB. Delafloxacin was active against MRSA, MR-CoNS, viridans group streptococci, beta-hemolytic streptococci, and penicillin- and macrolide-resistant S. pneumoniae strains ([Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). Isolates of E. faecium, ESBL-phenotype Enterobacteriaceae, ceftazidime-nonsusceptible P. aeruginosa, and Acinetobacter were considerably less susceptible to delafloxacin than the GPC and wild-type GNB. In contrast, delafloxacin showed activity comparable to that of the other fluoroquinolones tested against AmpC-producing strains of Enterobacteriaceae.

These data build on reports by previous investigators ([@B11], [@B12], [@B14], [@B19], [@B20]) and indicate that delafloxacin merits further study for the treatment of ABSSSI, RTI, and urinary tract infections where an acid environment and mixed GPC and GNB infections are common.

MATERIALS AND METHODS {#sec3}
=====================

Organisms. {#sec3-1}
----------

A total of 6,485 nonduplicate bacterial isolates were collected prospectively from 69 medical centers located in the United States (4,410 isolates) and from 44 medical centers located in 25 European countries (2,075 isolates) in the year 2014. All organisms were isolated from hospitalized patients with bloodstream infections (1,373 isolates), RTI (1,368 isolates), ABSSSI (2,177 isolates), UTI (735 isolates), intra-abdominal infections (267 isolates), and other types of infections (565 isolates). Isolates were identified to the species level at each participating medical center, and the identity was confirmed by the monitoring laboratory (JMI Laboratories, North Liberty, IA, USA) using standard bacteriological algorithms and methodologies or matrix-assisted laser desorption ionization--time of flight mass spectrometry (Bruker, Billerica, MA, USA), when necessary.

Antimicrobial susceptibility testing. {#sec3-2}
-------------------------------------

MICs were determined using the reference Clinical and Laboratory Standards Institute (CLSI) broth microdilution method ([@B25]). Quality control (QC) and interpretation of results were performed in accordance with the CLSI M100-S26 standard ([@B26]) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) 2016 guidelines ([@B27]). Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, and Proteus mirabilis were grouped as ESBL-phenotype strains on the basis of the CLSI screening criteria for potential ESBL production (i.e., a ceftazidime, ceftriaxone, or aztreonam MIC of ≥2 μg/ml) ([@B26]). Isolates of P. aeruginosa were classified as ceftazidime susceptible (MIC, ≤ 8 μg/ml) and ceftazidime nonsusceptible (MICs, \>8 μg/ml). QC strains were tested concurrently and included E. coli ATCC 25922 and ATCC 35218, S. aureus ATCC 29213, P. aeruginosa ATCC 27853, Enterococcus faecalis ATCC 29212, and S. pneumoniae ATCC 49619. All QC results were within published ranges.
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